Date | Price Target | Rating | Analyst |
---|---|---|---|
6/26/2024 | $2.00 | Neutral | Piper Sandler |
12/13/2022 | $3.00 → $2.00 | Buy → Neutral | Citigroup |
7/12/2022 | $6.50 | Neutral | Goldman |
12/20/2021 | $9.00 → $7.00 | Buy | Citigroup |
11/11/2021 | $7.00 → $6.00 | Equal-Weight | Barclays |
10/4/2021 | $9.00 | Buy | Citigroup |
8/20/2021 | $9.00 | Buy | Tigress Financial |
Piper Sandler initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $2.00
Citigroup downgraded MultiPlan from Buy to Neutral and set a new price target of $2.00 from $3.00 previously
Goldman initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $6.50
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
8-K - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
Piper Sandler analyst Jessica Tassan initiates coverage on MultiPlan (NYSE:MPLN) with a Neutral rating and announces Price Target of $2.
Gainers Anitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares increased by 4.24% to $2.04. The market value of their outstanding shares is at $9.1 million. PACS Group (NYSE:PACS) shares rose 3.95% to $31.52. The market value of their outstanding shares is at $4.8 billion. MultiPlan (NYSE:MPLN) shares moved upwards by 3.49% to $0.45. The market value of their outstanding shares is at $290.3 million. Nanoviricides (AMEX:NNVC) stock moved upwards by 2.01% to $2.48. The market value of their outstanding shares is at $29.2 million. Calidi Biotherapeutics (AME
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
Curren Katz Named Senior Vice President, Chief Data Science Officer Tara O'Neil Promoted to General Counsel; Scott Mays Promoted to SVP, Legal and Deputy General Counsel MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced an addition to its leadership team and two internal promotions within its Legal team, showcasing the company's deep pool of talent. Curren Katz, PhD has been appointed Chief Data Science Officer. In this newly created role, Katz will lead and unify the company's efforts and ac
Uniting the combined strengths of two leading healthcare organizations to address financial barriers to patient care. MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, and the National Rural Health Association (NRHA), a non-profit membership organization that provides leadership on rural health issues, announced today a strategic alliance to improve access to high-quality healthcare services in rural communities by empowering rural healthcare providers with innovative technology and actionable insights. In to
MultiPlan Common Stock to Begin Trading on a Split-Adjusted Basis on September 23, 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, today announced that the previously announced 1-for-40 reverse stock split of its outstanding shares of Class A common stock (the "common stock") became effective as of September 20, 2024 at 5:00 p.m. Eastern Time (the "Split Effective Time"). The common stock will continue trading on the New York Stock Exchange ("NYSE") under the existing symbol (MPLN) and will begin trading on a split-adjusted bas
3 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
– Q2 2024 Revenues of $233.5 million, Net Loss of $576.7 million (including a $553.7 million impairment of goodwill), and Adjusted EBITDA of $146.7 million – Identified potential medical cost savings of approximately $6.2 billion in Q2 2024, up 9% from Q2 2023 and up 8% from Q1 2024 – CFO transition plan announced MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the second quarter ended June 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton s
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, and hold its conference call that morning at 9:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=f096f8c3&confId=66913. Upon registration, you will receive an email with the conference dial-in details and
– Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million – Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 – Repurchased or repaid $24.4 million of face value of debt, including $21.1 million of 6.0% Senior Convertible PIK Notes MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today r
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country. The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Cer
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions, to the U.S. healthcare industry, today announced that Great Place To Work® and Fortune magazine have recognized the Company as one of the Best Workplaces in New York™ for 2024. This marks the second consecutive year MultiPlan has been named to this prestigious list. "Our inclusion on this list makes clear the unwavering investment we make in our employees' long-term success," said Carol Nutter, SVP and Chief People Officer at MultiPlan. "MultiPlan prides itself on maintainin